Skip to main content

Table 1 Analysis of Mammary Gland Growth

From: A moderate elevation of circulating levels of IGF-I does not alter ErbB2 induced mammary tumorigenesis

Group

Wild Type (control)

Transgenic (TTR-IGF-I)

Average. % Fat Pad Filled 4 wks

26%

28%

Average. % Fat Pad Filled 6 wks

80%

87%

Average. % Fat Pad Filled 9 wks

82%

82%

  1. There was no difference in mammary gland development compared to age-matched wild types at 4, 6 and 9 weeks of age as determined by percent of the mammary fat pad filled with the ductal tree. N = 20 for WT and TG at 4 wks of age; N = 4 for WT and 7 for TG at 6 wks of age; N = 7 for WT and N = 8 for TG at 9 wks of age. WT = wild type and TG = TTR-IGF-I
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us